As a result of a number of recently reported equine fatalities associated with the use of Medroxyprogesterone (MPA), US Equestrian will reconvene its MPA Panel to further analyze the use of this substance in horses competing at USEF-licensed competitions.
This latest information on equine fatalities associated with the use of MPA underscores the need for the MPA Panel to meet and review the critical information about this substance in order to provide our members with the information they need to protect their equine partners.
The MPA Panel was first convened in the winter to 2017 due to discussion in the veterinary community and the emergence of research regarding the efficacy of MPA in competition horses. Specifically, the question focused on how MPA affects the competition horse, since research indicated that MPA does not interrupt estrus in mares. This was especially important due to its increased use in geldings and stallions, and also to the reports of increased dosages being administered.
Following discussions at public hearings and town halls, as well as feedback from our members, the MPA Panel recommended that we continue to monitor the use of MPA, including implementation of MPA-specific medication reports in order to capture more information on dosage, administration schedules, and the continued presence of the substance in a horse’s system after the last known administration. However, the recent reports of equine fatalities have raised greater concern regarding the safety of this substance in horses.
US Equestrian remains steadfast in our efforts to protect human and equine athletes. As such, we will update our membership on any changes to the permitted use of MPA. In the interim, USEF strongly discourages the use of MPA by its members and also recommends that you consult with your veterinarian.
It’s time to meet the teams of the 2022 USEA Intercollegiate Eventing Championships! A total of 92 competitors, 12 schools, and 23 teams will be competing at the 2022 USEA Intercollegiate Eventing Championships on May 21-22 at Chattahoochee Hills H.T. in Fairburn, Georgia.
Entries are strong leading up to the exciting return of the MARS Bromont CCI that is taking place June 8-12 in rural Bromont, Quebec. Bromont is a popular destination for North American competitors who are eager to return to this 1976 Olympic Games venue just 90 minutes from Burlington, Vermont.
Five-star season is well underway and four U.S.-based pairs have turned their focus toward the CCI5*-L at the Longines Luhmühlen Horse Trials which takes place June 16-19 in Salzhausen, Germany. We caught up with each rider to get their thoughts on their decision to make the trek overseas and what they hope their horses glean from the experience.